Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis (Q46718334)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2005

edit

Language	Label	Description	Also known as
English	Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis	scientific article published in October 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

title

Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

author name string

Vukmanovic-Stejic M

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

McQuaid A

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

Birch KE

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

Reed JR

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

Macgregor C

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

Rustin MH

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

Akbar AN

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

language of work or name

English

0 references

publication date

1 October 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

published in

British Journal of Dermatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

volume

153

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

page(s)

750-757

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

cites work

Tacrolimus treatment of atopic eczema/dermatitis syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Identification of regulatory T cells in tolerated allografts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

The role of suppressor T cells in regulation of immune responses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Role of regulatory T cells in allergy and asthma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

T regulatory cells in atopic dermatitis and subversion of their activity by superantigens

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06675.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2133.2005.06675.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

PubMed publication ID

16181456

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16181456

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16181456

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46718334&oldid=2128034508"